Eugit Therapeutics
YC S22San Francisco, US · Founded 2022 · 2 employees · 1 known investors
Tissue Targeting Therapies develops therapeutics targeting specific tissues using computational genomics and immunology. The company serves patients through drug development in the biotech/medtech space.
Also known as Eugit · Eugit Therapeutics Inc · EUGIT Tx
BiotechHealthtechMedical DevicesCell TherapySynthetic BiologyTherapeuticsOncologyBiotechnologyUnited States of AmericaAmerica / Canada
Founders & leadership· Y Combinator alumni (S22)
Eugit Therapeutics was founded in 2022 by Nizar Batada, Yoshi Fukazawa, and George Church.
NB
Nizar BatadainCo-FounderHe previously worked as a scientist at 23andMe and held a tenure-track position at the University of Edinburgh, with a PhD in Biophysics from Stanford and research background in cancer genomics and bioinformatics.
YF
Yoshi FukazawainVP of Research / Co-Founder
GC
George ChurchinScientific Advisor / Co-Founder
Investors · 1
In the news
Frequently asked questions
- What does Eugit Therapeutics do?
- Tissue Targeting Therapies develops therapeutics targeting specific tissues using computational genomics and immunology. The company serves patients through drug development in the biotech/medtech space.
- Who founded Eugit Therapeutics?
- Eugit Therapeutics was founded by Nizar Batada, Yoshi Fukazawa, George Church in 2022.
- Who are Eugit Therapeutics's investors?
- Eugit Therapeutics's investors include Y Combinator.
- Where is Eugit Therapeutics headquartered?
- Eugit Therapeutics is headquartered in San Francisco, US.